CDC logoSafer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Draft Document for Public Review and Comment:

Process for Updating the List of Hazardous Drugs (Appendix A) for the NIOSH Alert on Antineoplastic and Other Hazardous Drugs in Health Care Settings
NIOSH Docket #105-A

Introduction and Purpose

The National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (CDC) is requesting comment on proposed additions and deletions to the list of hazardous drugs (Appendix A).  The NIOSH Alert was published in September 2004 (http://www.cdc.gov/niosh/docs/2004-165/).  Following the publication of the Alert, NIOSH reviewed 70 new FDA-approved drugs and approximately 60 that had received special warnings.  NIOSH developed a list of approximately 60 drugs that appeared to fit the NIOSH definition for a hazardous drug.  Following a public meeting, NIOSH posted the proposed list in the Federal Register in July 2007.  NIOSH then convened a panel of 10 external reviewers to review the NIOSH list and the public comments.  NIOSH reviewed the comments from the external reviewers and revised the proposed list to 24 additions and one deletion.

Charge to Reviewers

NIOSH is requesting public comment on the proposed additions and deletions to the list of hazardous drugs (Appendix A) of NIOSH Alert.

Proposed Additions and Deletions to Appendix A

ProposedChanges.pdf
(32kb; 3 pages)
NIOSH Response to Peer Review Comments ResponsetoPeer.pdf
(52kb; 8 pages)
NIOSH Response to Public Comments ResponsetoPublic.pdf
(36kb; 6 pages)
Federal Register Notice: Updating the List of Hazardous Drugs for the NIOSH Alert: Additions and Deletions to the NIOSH Hazardous Drug List Federal Register Notice
External Link: http://edocket.access.gpo.gov/2009/E9-9779.htm
The free Adobe Acrobat Reader is needed to view these files. get acrobat reader

Time Frame for Review

Written comments on the docket will be accepted from April 29, 2009 through June 30, 2009.  Written comments can be sent to the NIOSH Docket Office, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C-34, Cincinnati, OH 45226 by the close of business June 30, 2009.  All material submitted to the Agency should reference docket number NIOSH-105A.  All electronic comments should be formatted as Microsoft Word and make reference to docket number NIOSH-105A.

Comments will be accepted until 5:00 pm on June 30, 2009. 

NIOSH Draft Documents for Public Review

 

NIOSH Home |  NIOSH Search  | Site Index  | Topic List | Contact Us